Differential expression of SARS-CoV-2 entry proteins (ACE2 and TMPRSS2) and STAT1/2 in entorhinal cortex of control, AD, and DS-AD individuals with no history of COVID-19. This evidence concerns the gene ACE2 and Alzheimer disease.